How big do peptides like BPC-157 get by 2030, and do they work?

Question

Igor Beuker · Accepted Answer

Healing peptides like BPC-157 are the next Ozempic, without the science. A peptide is a short chain of amino acids that copies a hormone. Insulin is one. Ozempic is one. The wellness industry sells the sequel: if a peptide can switch off hunger, another can heal your tendon, grow your muscle, slow your aging. BPC-157, TB-500, ipamorelin, CJC-1295, the "Wolverine stack".

Ozempic proved the needle. The craze sells the needle without the proof.

Why? Because the doctor says rest and the influencer says inject. Men of 35 to 60 with a torn shoulder, a slow knee, a slower metabolism, and Joe Rogan, Hailey Bieber and Gary Brecka on the phone in their hand. A 12-year-old athlete was brought to a sports doctor in 2026 for BPC-157. Nobody counts the users, and that is the point: they buy by phone or online, mix Chinese powder with sterile water in the kitchen, and inject themselves.

Medically it does not hold yet. The entire published human record on BPC-157 is about 14 people. Rodents heal. Humans have not been tested. In July 2026 an FDA panel shaped by RFK Jr. voted to lift the ban anyway.

Then the grey market: of 469 BPC-157 samples tested, 68% failed on quality. 2 women in Las Vegas ended in hospital after unknown peptides at an anti-aging clinic.

Sellers call it the next longevity breakthrough. Analysts disagree by 5 times on the market. Ozempic alone already books $100 billion a year.

My call: peptide drugs pass $150 billion by 2030, healing peptides go legal by phone across the US, Europe still bans them, BPC-157 gets its first 1,000-person trial, and the first peptide death lawsuit reaches a US court.

If it did not come from a pharmacy with your name on it, do not inject it.

Key figures: Peptide drugs sold worldwide, Ozempic and Wegovy included: about $100 billion in 2026, $150 billion by 2030 on my call, against the analysts' consensus of $84 billion. Human proof behind BPC-157, the most injected healing peptide: about 14 people in the entire published record; peptide drugs approved by the FDA since 2016: 34; non-approved peptides with a large human trial: 0. Who injects healing peptides: 60% men and 40% women, aged 35 to 60, for weight (40%), injury recovery (25%), anti-aging (20%) and performance (15%); no government counts them, they buy online or by phone. The grey market: 469 BPC-157 samples tested in 2026, 68% failed on quality, doses off by up to 80%; crypto-paid peptide sales pass $100 million a year; the FDA panel of July 2026 voted to allow compounding of 7 peptides, Europe and the UK license none.

Peptides like bpc-157: $150 billion by 2030, 14 humans of proof.